Caxton Associates LP Adaptive Biotechnologies Corp Transaction History
Caxton Associates LP
- $3.12 Billion
- Q4 2024
A detailed history of Caxton Associates LP transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Caxton Associates LP holds 123,287 shares of ADPT stock, worth $932,049. This represents 0.02% of its overall portfolio holdings.
Number of Shares
123,287Holding current value
$932,049% of portfolio
0.02%Shares
3 transactions
Others Institutions Holding ADPT
# of Institutions
224Shares Held
146MCall Options Held
19.6KPut Options Held
27.2K-
Viking Global Investors LP30MShares$227 Million0.61% of portfolio
-
Rubric Capital Management LP New York, NY14.6MShares$110 Million1.45% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$88.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$81 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.42MShares$71.2 Million0.49% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.08B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...